UnitedHealth Group Incorporated stock: AI gains shape 2027 outlook

UnitedHealth Group used its third-quarter earnings call on October 13, 2026, to provide a more detailed view of how artificial intelligence and operating reforms could support growth from 2027. The company said it had expanded AI-enabled chart summarization to more than 40% of its employed clinicians and reduced chart review time by 33%, according to its earnings remarks.

What has changed since the last report

The additional operating detail is relevant because it gives investors measurable indicators for the company's modernization program. UnitedHealth said AI-enabled information gathering and research shortened appeal cycle times by 26%. It also expects to complete previously announced prior-authorization reforms by year-end, with the reforms intended to reduce total prior authorizations by 30%.

Management continues to frame 2027 as a transition toward renewed growth. The company said the lower end of its long-term 13% to 16% adjusted earnings growth range was a reasonable starting point, while also warning that medical trends remain elevated. Optum Insight is investing in healthcare-specific AI products, while Optum Health is emphasizing integrated value-based care.

Results provide the operating baseline

In its third-quarter release, UnitedHealth reported revenue of USD 112.7 billion and earnings from operations of USD 6.6 billion for the quarter ended September 30. Adjusted earnings per share were USD 4.69, and full-year 2026 adjusted earnings guidance was raised to at least USD 20.50 per share.

The consolidated medical care ratio was 88.4%, compared with 89.9% a year earlier. Management nevertheless highlighted continuing pressure from specialty pharmacy, acute-care intensity and other medical trends. That balance between improved execution and still-high costs remains central to the investment case.

Trading context for investors

Lang & Schwarz quoted UnitedHealth Group at EUR 366.30 on October 29, 2026, at 17:05:49 Berlin time. The verified Xetra close from October 28 was EUR 372.2519, putting the current quote 1.60% below that prior-session reference. The comparison is a market snapshot, not a causal reaction attributed to the company's operating update.

UnitedHealth Group's real-time quote of UnitedHealth Group Incorporated stock provides the latest trading context.

Market context: The S&P 500 remains the relevant broad-market reference for this U.S.-listed healthcare group.

More news and analyses on UnitedHealth Group Incorporated stock